PTEN and cancer: PTEN and/or activating mutations in the proto-typical lipid kinase PI3 K have emerged as some of the most frequent events associated with human cancer and as a result the PI3 K pathway has become a highly sought-after target for cancer therapies (Papa and Pandolfi 2019).